SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

79,310.01 2,008.61
( 2.60%)

Global Indices

Nasdaq

53,347.89 1,540.17
(2.97%)

Dow Jones

7,717.41 127.49
(1.68%)

Hang Seng

60,935.13 -1,253.50
(-2.02%)

Nikkei 225

10,852.07 213.64
(2.01%)

Forex

USD-INR

94.73 -0.07
(-0.07%)

EUR-INR

105.99 -0.12
(-0.11%)

GBP-INR

127.06 -0.04
(-0.03%)

JPY-INR

0.60 0.00
(-0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Godavari Drugs Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530317

INE362C01012

71.0541395

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

33.53

130.26

EPS(TTM)

Face Value()

Div & Yield %

3.56

Back

MOIL standalone net profit declines 12.29% in the September 2026 quarter

Nov 02,2026

Net profit of MOIL declined 12.29% to Rs 61.78 crore in the quarter ended September 2026 as against Rs 70.44 crore during the previous quarter ended September 2025. Sales rose 10.94% to Rs 369.13 crore in the quarter ended September 2026 as against Rs 332.74 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	369.13	332.74	11
OPM %	29.70	29.91	-
PBDT	125.51	129.79	-3
PBT	77.14	89.76	-14
NP	61.78	70.44	-12

79,310.01 2,008.61 ( 2.60%)

53,347.89 1,540.17 (2.97%)

7,717.41 127.49 (1.68%)

60,935.13 -1,253.50 (-2.02%)

10,852.07 213.64 (2.01%)

94.73 -0.07 (-0.07%)

105.99 -0.12 (-0.11%)

127.06 -0.04 (-0.03%)

0.60 0.00 (-0.31%)